Advanced Search
Contact | Corporate | Help

Ph I/II Ipilimumab Vemurafenib Combo

Sponsors:
  • Bristol-Myers Squibb
  • Roche-Genentech
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Melanoma
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Ipilimumab (BMS-734016)
  • Biological: Vemurafenib
Enrollment:
50

Additional information about NCT01400451.


SourceSolution © 2008-2012